SMPD1 and acid sphingomyelinase deficiency: Olipudase alfa, a recombinant human acid sphingomyelinase, is an enzyme replacement therapy for the treatment of non-neurologic manifestations of acid sphingomyelinase deficiency that has been showing promising results [4,15].